US 10167334
Treatment of cancer using anti-TGF-BETA and PD-1 antibodies
granted A61KA61K2039/507A61K2039/57
Quick answer
US patent 10167334 (Treatment of cancer using anti-TGF-BETA and PD-1 antibodies) held by The Regents of the University of California expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/507, A61K2039/57, A61P, A61P35/00